Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation

Published:2017-02-06 Issue:3 Volume:15 Page:473-476
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Achilles A.¹,Mohring A.¹,Dannenberg L.¹,Grandoch M.²,Hohlfeld T.²,Fischer J. W.²,Levkau B.³,Kelm M.¹,Zeus T.¹,Polzin A.¹

Affiliation:

1. Division of Cardiology; Pulmonology; and Vascular Medicine; Heinrich Heine University Medical Center Dusseldorf; Dusseldorf Germany

2. Institute for Pharmacology and Clinical Pharmacology; Heinrich Heine University; Dusseldorf Germany

3. Institute of Pathophysiology; West German Heart and Vascular Center; University Hospital Essen; University of Duisburg-Essen; Essen Germany

Funder

Heinrich-Heine-Universität Düsseldorf

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13595/fullpdf

Reference6 articles.

1. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

2. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism;Schulman;N Engl J Med,2013

3. Idarucizumab for Dabigatran Reversal;Pollack;N Engl J Med,2015

4. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding;Tantry;J Am Coll Cardiol,2013

5. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study;Stone;Lancet,2013

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling;International Journal of Molecular Sciences;2024-08-10

2. Comparative Cardioprotective Effectiveness: NOACs vs. Nattokinase—Bridging Basic Research to Clinical Findings;Biomolecules;2024-08-07

3. Inhibitory effect of rivaroxaban on protease-activated receptor-2 in circulating neutrophils among patients with atrial fibrillation;IJC Heart & Vasculature;2024-06

4. Ex Vivo Antiplatelet Effects of Oral Anticoagulants;Journal of Cardiovascular Development and Disease;2024-03-31

5. Perioperative Treatment with Rivaroxaban and Dabigatran on Changes of Coagulation and Platelet Activation Biomarkers following Left Atrial Appendage Closure;Cardiovascular Therapeutics;2024-03-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3